Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, July 21, 2024 | Back issues
Courthouse News Service Courthouse News Service

Steven Sklar v. Amarin Corp. PLC; Joseph Zakrzewski

Amarin misrepresented the Food and Drug Administration's intent to approve its product, Vascepa, and the CEO dumped $11 million of his own shares at the inflated prices, a class claims.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...